» Articles » PMID: 36153317

Structure of the Malaria Vaccine Candidate Pfs48/45 and Its Recognition by Transmission Blocking Antibodies

Overview
Journal Nat Commun
Specialty Biology
Date 2022 Sep 24
PMID 36153317
Authors
Affiliations
Soon will be listed here.
Abstract

An effective malaria vaccine remains a global health priority and vaccine immunogens which prevent transmission of the parasite will have important roles in multi-component vaccines. One of the most promising candidates for inclusion in a transmission-blocking malaria vaccine is the gamete surface protein Pfs48/45, which is essential for development of the parasite in the mosquito midgut. Indeed, antibodies which bind Pfs48/45 can prevent transmission if ingested with the parasite as part of the mosquito bloodmeal. Here we present the structure of full-length Pfs48/45, showing its three domains to form a dynamic, planar, triangular arrangement. We reveal where transmission-blocking and non-blocking antibodies bind on Pfs48/45. Finally, we demonstrate that antibodies which bind across this molecule can be transmission-blocking. These studies will guide the development of future Pfs48/45-based vaccine immunogens.

Citing Articles

Computational Development of Transmission-Blocking Vaccine Candidates Based on Fused Antigens of Pre- and Post-fertilization Gametocytes Against .

Adeleke M Bioinform Biol Insights. 2025; 19:11779322241306215.

PMID: 40034580 PMC: 11873872. DOI: 10.1177/11779322241306215.


Structure of endogenous Pfs230:Pfs48/45 in complex with potent malaria transmission-blocking antibodies.

Bekkering E, Yoo R, Hailemariam S, Heide F, Ivanochko D, Jackman M bioRxiv. 2025; .

PMID: 39990443 PMC: 11844449. DOI: 10.1101/2025.02.14.638310.


Targeting Bottlenecks in Malaria Transmission: Antibody-Epitope Descriptions Guide the Design of Next-Generation Biomedical Interventions.

Yoo R, Jore M, Julien J Immunol Rev. 2025; 330(1):e70001.

PMID: 39907429 PMC: 11796336. DOI: 10.1111/imr.70001.


Target-agnostic identification of human antibodies to sexual forms reveals cross-stage recognition of glutamate-rich repeats.

Amen A, Yoo R, Fabra-Garcia A, Bolscher J, Stone W, Bally I Elife. 2025; 13.

PMID: 39817720 PMC: 11737873. DOI: 10.7554/eLife.97865.


Proceedings of the Conference "CMV Vaccine Development-How Close Are We?" (27-28 September 2023).

Schleiss M, Crooks C, Karthigeyan K, Kruc R, Otero C, Wang H Vaccines (Basel). 2024; 12(11).

PMID: 39591134 PMC: 11598149. DOI: 10.3390/vaccines12111231.


References
1.
Kapulu M, Da D, Miura K, Li Y, Blagborough A, Churcher T . Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparum. Sci Rep. 2015; 5:11193. PMC: 4463016. DOI: 10.1038/srep11193. View

2.
Winn M, Ballard C, Cowtan K, Dodson E, Emsley P, Evans P . Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr. 2011; 67(Pt 4):235-42. PMC: 3069738. DOI: 10.1107/S0907444910045749. View

3.
Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O . Highly accurate protein structure prediction with AlphaFold. Nature. 2021; 596(7873):583-589. PMC: 8371605. DOI: 10.1038/s41586-021-03819-2. View

4.
Templeton T, Kaslow D . Identification of additional members define a Plasmodium falciparum gene superfamily which includes Pfs48/45 and Pfs230. Mol Biochem Parasitol. 1999; 101(1-2):223-7. DOI: 10.1016/s0166-6851(99)00066-3. View

5.
McGibbon R, Beauchamp K, Harrigan M, Klein C, Swails J, Hernandez C . MDTraj: A Modern Open Library for the Analysis of Molecular Dynamics Trajectories. Biophys J. 2015; 109(8):1528-32. PMC: 4623899. DOI: 10.1016/j.bpj.2015.08.015. View